Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: Investigation in rat heart with acute infarction

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 663-682

  Paul, Arghya ^a   Nayan, Madhur ^b   Khan, Afshan Afsar ^a   Shum Tim, Dominique ^b   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Angiogenesis; Baculovirus; Combined stem cell gene therapy; Myocardial therapy; Nanoparticle; Tissue engineering

Indexed keywords

ANGIOPOIETIN 1; DEOXYRIBONUCLEIC ACID NANOPARTICLE; NANOPARTICLE; TRANSACTIVATING TRANSCRIPTIONAL ACTIVATOR PEPTIDE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; CAPILLARY DENSITY; COMPLEX FORMATION; CONTROLLED STUDY; DNA MODIFICATION; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEART PERFORMANCE; HUMAN; HUMAN CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; VIRAL GENE DELIVERY SYSTEM; ADIPOCYTE; ANIMAL; BIOSYNTHESIS; CELL GROWTH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; GENE THERAPY; GENETICS; HEART INFARCTION; HEART STROKE VOLUME; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TRANSGENE; TRANSPLANTATION; WOUND HEALING;

RATTUS;

ADIPOCYTES; ANGIOPOIETIN-1; ANIMALS; BACULOVIRIDAE; CELL GROWTH PROCESSES; CELL SURVIVAL; GENE THERAPY; HUMANS; MALE; MYOCARDIAL INFARCTION; NANOPARTICLES; RATS; STEM CELL TRANSPLANTATION; STEM CELLS; STROKE VOLUME; TISSUE ENGINEERING; TRANSGENES; WOUND HEALING;

EID: 84861811944     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S26882     Document Type: Article

References (37)

1. Zhang C, Sun A, Zhang S, et al. Eff icacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up. Clin Cardiol. 2010;33(6):353-360.
2. Surder D, Schwitter J, Moccetti T, et al. Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). Am Heart J. 2010; 160(1):58-64.
3. Atoui R, Shum-Tim D, Chiu RC. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells. " Ann Thorac Surg. 2008;86(1):327-334.
4. Das H, George JC, Joseph M, et al. Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One. 2009;4(1):e7325.
5. Kim SH, Moon HH, Kim HA, Hwang KC, Lee M, Choi D. Hypoxiainducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury. Mol Ther. 2011;19(4): 741-750.
6. Chen SL, Zhu CC, Liu YQ, et al. Mesenchymal stem cells genetically modified with the angiopoietin-1 gene enhanced arteriogenesis in a porcine model of chronic myocardial ischaemia. J Int Med Res. 2009; 37(1):68-78.
7. Phillips JE, Gersbach CA, Garcia AJ. Virus-based gene therapy strategies for bone regeneration. Biomaterials. 2007;28(2):211-229.
8. Donsante A, Miller DG, Li Y, et al. AAV vector integration sites in mouse hepatocellular carcinoma. Science. 2007;317(5837):477.
9. Chuang CK, Wong TH, Hwang SM, et al. Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Mol Ther. 2009;17(5): 889-896.
10. Paul A, Prakash S. Baculovirus reveals a new pH-dependent direct cell-fusion pathway for cell entry and transgene delivery. Future Virol. 2010;5(5):533-537.
11. Paul A, Shum-Tim D, Prakash S. Investigation on PEG integrated alginate-chitosan microcapsules for myocardial therapy using marrow stem cells genetically modified by recombinant baculovirus. Cardiovasc Eng Technol. 2010;1(2):154-164.
12. Lo SL, Wang S. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials. 2008;29(15):2408-2414.
13. Paul A, Binsalamah ZM, Khan AA, et al. A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy. Biomaterials. 2011;32(32):8304-8318.
14. Paul A, Cantor A, Shum-Tim D, Prakash S. Superior cell delivery features of genipin crosslinked polymeric microcapsules: preparation, in vitro characterization and pro-angiogenic applications using human adipose stem cells. Mol Biotechnol. 2011;48(2):116-127.
15. Cho KS, Park HK, Park HY, et al. IFATS collection: immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells. 2009;27(1):259-265.
16. Duckers HJ Sr, Houtgraaf J, van Guens RJ, Fernandez-Aviles FJ, Serruys PW. First-in-man experience of adipose tissue-derived regenerative cell transplantation in the treatment of patients with an acute ST-elevation myocardial infarction (APOLLO trial). J Am Coll Cardiol. 2010;55:A100. E934.
17. Metzele R, Alt C, Bai XW, et al. Human adipose tissue-derived stem cells exhibit proliferation potential and spontaneous rhythmic contraction after fusion with neonatal rat cardiomyocytes. FASEB J. 2011;25(3):830-839.
18. Rehman J, Traktuev D, Li JL, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1292-1298.
19. Tao Z, Chen B, Tan X, et al. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci U S A. 2011;108(5):2064-2069.
20. Zhou L, Ma W, Yang Z, et al. VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther. 2005;12(3):196-202.
21. Samuel SM, Akita Y, Paul D, et al. Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes. 2010;59(1):51-60.
22. Takahashi K, Ito Y, Morikawa M, et al. Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction. Mol Ther. 2003;8(4):584-592.
23. Ye L, Haider HK, Jiang S, Ge R, Law PK, Sim EK. In vitro functional assessment of human skeletal myoblasts after transduction with adenoviral bicistronic vector carrying human VEGF165 and angiopoietin-1. J Heart Lung Transplant. 2005;24(9):1393-1402.
24. Paul A, Khan AA, Shum-Tim D, Prakash S. BacMam virus transduced cardiomyoblasts can be used for myocardial transplantation using APPEG-A microcapsules: molecular cloning, preparation, and in vitro analysis. J Biomed Biotechnol. 2010;2010:858094.
25. Wang Z, Cui M, Sun L, et al. Angiopoietin-1 protects H9c2 cells from H2O2-induced apoptosis through AKT signaling. Biochem Biophys Res Commun. 2007;359(3):685-690.
26. Li J, Niu XL, Madamanchi NR. Leukocyte antigen-related protein tyrosine phosphatase negatively regulates hydrogen peroxide-induced vascular smooth muscle cell apoptosis. J Biol Chem. 2008;283(49): 34260-34272.
27. Atoui R, Asenjo JF, Duong M, Chen G, Chiu RC, Shum-Tim D. Marrow stromal cells as universal donor cells for myocardial regenerative therapy: their unique immune tolerance. Ann Thorac Surg. 2008;85(2):571-579.
28. Paul A, Srivastava S, Chen G, Shum-Tim D, Prakash S. Functional assessment of adipose stem cells for xenotransplantation using myocardial infarction immunocompetent models: comparison with bone marrow stem cells. Cell Biochem Biophys. 2011. [Epub ahead of print.] doi: 10.1007/s12013-011-9323-0.
29. Stewart DJ, Kutryk MJ, Fitchett D, et al. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol Ther. 2009; 17(6):1109-1115.
30. Cai L, Johnstone BH, Cook TG, et al. IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells. 2009;27(1):230-237.
31. Jardin BA, Zhao Y, Selvaraj M, et al. Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system. J Biotechnol. 2008;135(3):272-280.
32. Chen CY, Lin CY, Chen GY, Hu YC. Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv. 2011;29(6):618-631.
33. Kim YK, Choi JY, Jiang HL, et al. Hybrid of baculovirus and galactosylated PEI for efficient gene carrier. Virology. 2009;387(1):89-97.
34. Yang Y, Lo SL, Yang J, et al. Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials. 2009;30(29):5767-5774.
35. Chen HZ, Wu CP, Chao YC, Liu CY. Membrane penetrating peptides greatly enhance baculovirus transduction efficiency into mammalian cells. Biochem Biophys Res Commun. 2011;405(2):297-302.
36. Paul A, Ge Y, Prakash S, Shum-Tim D. Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy. Regen Med. 2009;4(5):733-745.
37. Liu XB, Jiang J, Gui C, Hu XY, Xiang MX, Wang JA. Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3K/Akt pathway. Acta Pharmacol Sin. 2008;29(7):815-822.